What alternative medication can be ordered for a patient with hot flashes when Voezah (generic name not specified, possibly referring to a brand name) is denied by insurance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternative Medications for Hot Flashes When Veozah is Denied

Start with gabapentin 900 mg/day as your first-line alternative, as it reduces hot flash severity by 46% and has no drug interactions, no sexual dysfunction, and no withdrawal syndrome. 1

Primary Pharmacologic Options

Gabapentin (First Choice)

  • Dosing: Start at 300 mg/day and titrate up to 900 mg/day over 1-2 weeks 1
  • Efficacy: Reduces hot flash severity by 46-49% at 900 mg/day compared to 15-21% with placebo 1
  • Advantages over other options:
    • No drug interactions (critical advantage over SSRIs/SNRIs) 1
    • No sexual dysfunction 1
    • No withdrawal syndrome unlike venlafaxine or paroxetine 1
    • Particularly useful when given at bedtime for patients with sleep disturbance from hot flashes 1
  • Side effects: Dizziness, unsteadiness, and drowsiness affect up to 20% but markedly improve after the first week and largely resolve by week 4 1

Venlafaxine (Second Choice)

  • Dosing: Start at 37.5 mg daily, increase to 75 mg daily after 1 week 1
  • Efficacy: Reduces hot flashes by 61% at 75 mg/day compared to 27% with placebo 1, 2
  • Key consideration: If patient is on tamoxifen, venlafaxine is preferred over paroxetine because it has minimal effects on CYP2D6 and doesn't interfere with tamoxifen metabolism 1, 2
  • Side effects: Dry mouth, reduced appetite, nausea, constipation, and possible sexual dysfunction 1
  • Important: Must be gradually tapered on discontinuation to minimize withdrawal symptoms 1

SSRIs (Third Choice)

  • Paroxetine: 10-20 mg daily (start at 10 mg, increase after 1 week if needed) reduces hot flashes by 50-65% 1, 2
  • Citalopram: Also effective with 50-65% reduction 2
  • Critical warning: Avoid paroxetine and fluoxetine in patients taking tamoxifen - they are potent CYP2D6 inhibitors that interfere with conversion of tamoxifen to its active metabolite endoxifen 1, 2
  • Preferred SSRI if on tamoxifen: Citalopram has minimal impact on tamoxifen metabolism 1, 2

Clonidine (Fourth Choice)

  • Reduces hot flashes by up to 46% 2
  • Less effective and slower onset than venlafaxine, though may be better tolerated 1
  • Side effects: Sleep difficulties, dry mouth, fatigue, dizziness, nausea 1

Clinical Decision Algorithm

Step 1: Assess if patient is on tamoxifen or other medications

  • If on tamoxifen: Choose gabapentin first, or venlafaxine/citalopram as alternatives. Never use paroxetine or fluoxetine 1, 2
  • If not on tamoxifen: Gabapentin remains first choice, but paroxetine becomes a reasonable alternative 1

Step 2: Consider patient-specific factors

  • If sleep disturbance is prominent: Gabapentin at bedtime is ideal due to somnolence side effect 1
  • If patient has bipolar disorder/manic depression: Avoid SSRIs/SNRIs due to risk of inducing mania 1
  • If patient is on MAO inhibitors: SSRIs and SNRIs are contraindicated 1

Step 3: Reassess at 4 weeks

  • If no response by 4 weeks, switch to a different class rather than continuing 1, 3
  • If venlafaxine fails, try paroxetine (if not on tamoxifen) or gabapentin 1

Common Pitfalls to Avoid

  • Don't use paroxetine or fluoxetine with tamoxifen - this is the most critical drug interaction that reduces tamoxifen efficacy 1, 2
  • Don't forget to taper SSRIs/SNRIs when discontinuing to avoid withdrawal syndrome 1
  • Don't continue ineffective treatment beyond 4 weeks - if no improvement by then, switch agents 1, 3
  • Don't add estrogen/progestin therapy in patients taking SERMs as they have potential interactions 1

Adjunctive Non-Pharmacologic Options

While pharmacologic therapy should be initiated, consider adding:

  • Weight loss if overweight/obese 1, 3
  • Cognitive behavioral therapy 1, 3
  • Acupuncture - shown equivalent to or better than venlafaxine or gabapentin in some studies 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hot Flashes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hot Flashes in Young Women on Hormonal Contraceptives

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.